PD1 Antibody and Lenalidomide as a Treatment for EBV-HLH or CAEBV
Clinical trial NCT04084626 · UNKNOWN
Trial details
- NCT number
- NCT04084626
- Sponsor
- Beijing Friendship Hospital
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-15
- Primary completion
- 2022-07-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.